HIV Point of Care (POC) Tests Pipeline by Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
HIV Point of Care (POC) Pipeline Market Report Overview
Point of Care Testing (POC) is typically performed by non-laboratory personnel outside the clinical laboratory close to where the patient is receiving care. The results obtained from such tests are used for clinical decision-making. The HIV Point of Care (POC) pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials.
Key Territories | · The US
· Europe · China · India · Japan |
Key Regulatory Paths | · PMA
· CE-IVD · 510(k) · NMPA · ICAC |
Leading Companies | · Abbott Rapid Diagnostics GmbH
· Aldatu Biosciences Inc · Altratech Ltd · Atomo Diagnostics Ltd · Baebies Inc |
Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
HIV Point of Care (POC) Pipeline Market Segmentation by Territories
A few of the key territories for HIV Point of Care (POC) pipeline products are the US, Europe, China, India, and Japan. As of December 2023, the US accounted for the highest number of pipeline products.
HIV Point of Care (POC) Pipeline Market Analysis by Territories, 2023 (%)
Buy the Full Report for More Territory Insights into the HIV Point of Care (POC) Pipeline Market
HIV Point of Care (POC) Pipeline Market Segmentation by Regulatory Paths
A few of the key regulatory paths followed by the HIV Point of Care (POC) pipeline market are PMA, CE-IVD, 510(k), NMPA, and ICAC. As of December 2023, PMA was the most followed pathway for pipeline products in the market.
HIV Point of Care (POC) Pipeline Market Analysis by Regulatory Paths, 2023 (%)
Buy the Full Report for More Regulatory Path Insights into the HIV Point of Care (POC) Pipeline Market
HIV Point of Care (POC) Pipeline Market – Competitive Landscape
A few of the key companies associated with the HIV Point of Care (POC) pipeline market are Abbott Rapid Diagnostics GmbH, Aldatu Biosciences Inc, Altratech Ltd, Atomo Diagnostics Ltd, Baebies Inc, among others.
Atomo Diagnostics Ltd: Atomo is headquartered in Sydney, New South Wales, Australia. The company has operations in South Africa, the UK and Australia. It is a medical device company that designs, develops, manufactures, and commercializes in-vitro diagnostic products. The company’s products are used for self-test consumer applications for detecting infectious diseases, measuring markers and hormone levels, and screening for chronic conditions.
Baebies Inc: The company is involved in developing new technology and new tests for healthcare professionals and parents worldwide. Thus, it helps save lives and make lives better for children. The company offers Seeker, a platform for newborn screening authorized by the FDA, to find lysosomal storage disorders.
HIV Point of Care (POC) Pipeline Market Analysis by Companies, 2023
Buy the Full Report for More Company Insights into the HIV Point of Care (POC) Pipeline Market
Segments Covered in the Report
HIV Point of Care (POC) Pipeline Market Territories Outlook
- The US
- Europe
- China
- India
- Japan
HIV Point of Care (POC) Pipeline Market Regulatory Paths Outlook
- PMA
- CE-IVD
- 510(k)
- NMPA
- ICAC
Scope
This report provides:
- Extensive coverage of the HIV Point of Care (POC) under development.
- Exhaustive list of major pipeline products and their details, including product description, licensing and collaboration details, and other developmental activities.
- Reviews of major players involved in the development of HIV Point of Care (POC) and lists all their pipeline projects.
- Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
- Key clinical trial data of ongoing clinical trials specific to pipeline products.
- Recent developments in the segment/industry.
Reasons to Buy
The report will enable you to:
- Formulate significant competitor information, analysis, and insights to improve R&D strategies.
- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain a competitive advantage.
- Identify and understand important and diverse types of HIV Point of Care (POC) under development.
- Develop market-entry and market-expansion strategies.
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
- Carry out In-depth analysis of the product’s current stage of development, territory, and estimated launch date.
Aldatu Biosciences Inc
Altratech Ltd
Atomo Diagnostics Ltd
Baebies Inc
BBB Technologies Inc
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
Binx Health Inc
Bio-AMD Inc
Biocartis Group NV
BioHelix Corp
Bluejay Diagnostics Inc
Calypte Biomedical Corporation
Centre International de Reference Chantal Biya
Cepheid Inc
ChipCare Corp
CrossLife Technologies Inc
Cue Inc
Daktari Diagnostics, Inc.
Diagnostics For All Inc
Diagnostics for the Real World (Europe) Ltd
Endeavor Sciences Inc
Epinex Diagnostics Inc
ERBA Molecular Ltd
Fluxergy LLC
GAIA Medical Institute LLC
genedrive plc
Group K Diagnostics
Guangzhou Wondfo Biotech Co Ltd
HA TECH Pty Ltd
HeatFlow Technologies Inc
Identifysensors LLC
Imperial College London
Integrated Diagnostics Inc (Inactive)
Intuitive Biosciences Inc
Jan Biotech Inc
Jinvator Bio Med GmbH
Johns Hopkins University
Lynntech Inc
Maxim Biomedical Inc
MedMira Inc
Micronics Inc
Molbio Diagnostics Pvt Ltd
MyMD Pharmaceuticals Inc
Nanobiosym Inc
Newmark Diagnostics LLC
Northwestern University
Osel Inc
Philmedi Co Ltd
Prenetics Ltd
QuantuMDx Group Ltd
Quidel Corp
Radisens Diagnostics Ltd
Rheonix Inc
Roche Diagnostics International Ltd
Sedia Biosciences Corp
Sensible Diagnostics Inc
Senzo Inc
TheoremDx Inc
Trinity Biotech Plc
University of Connecticut
University of Minnesota
UrSure Inc
Ustar Biotechnologies (Hangzhou) Ltd.
Virax Biolabs Group Ltd
Wave 80 Biosciences Inc
Yaathum Biotech Pvt Ltd
Table of Contents
Table
Figures
Frequently asked questions
-
Which territory had the highest number of products in the HIV Point of Care (POC) pipeline market?
As of December 2023, the US accounted for the highest number of products in the HIV Point of Care (POC) pipeline market.
-
Which was the most followed regulatory pathway in the HIV Point of Care (POC) pipeline market?
As of December 2023, PMA was the most followed pathway for pipeline products in the HIV Point of Care (POC) market.
-
Which are the major companies operating in the HIV Point of Care (POC) pipeline market?
A few of the key companies associated with the HIV Point of Care (POC) pipeline market are Abbott Rapid Diagnostics GmbH, Aldatu Biosciences Inc, Altratech Ltd, Atomo Diagnostics Ltd, Baebies Inc, among others.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.